AKT1 and osteosarcoma: Da et al. observed that CTAB concentrations ranging from 2–6 μM not only inhibited proliferation and induced cell cycle arrest in osteosarcoma cells but also promoted apoptosis by inhibiting the hyperactive PI3K/AKT pathway [81].